The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Optishield is a low vision aid for patients and offers a hands-free alternative for optometrists.
The Oxford AHSN Accelerator programme, in collaboration with BioCity and regional partners from the NHS, industry and research within the Thames Valley, offers a launchpad for entrepreneurs and their ventures to move from idea to market. CanSense and Dravya Discovery won a place on the intensive eight-week programme and pitched to investors on the final day of the Accelerator programme in November 2019.
Nu Vision eye treatments offer an alternative to eye surgery by using preserved amniotic membrane (membrane from placentas) to treat damaged corneas and promote healing. The products are unique, as the material is preserved making it easy to store and accessible to hospitals. The company is in the process of expanding into using their product to facilitate the treatment of chronic wounds, such as diabetic foot ulcers.
Falls are the most common cause of hospital admission for people age over 65 and the rate of falls is almost two times as high in older adults with a visual impairment. How can we use innovation to increase rates of vision screenings and reduce instances of falls the elderly?
